Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program
Status:
Completed
Trial end date:
2016-05-06
Target enrollment:
Participant gender:
Summary
This study is multicentric, single-blind, and interventional with a randomization into two
parallel arm, between a standard of care information and an additional information of the
patient, with a 12 month follow up.
The aim of this study is to evaluate the effectiveness of a personalized information program
versus information provided from standard of care in patients taking Xarelto for Stroke
Prevention in Atrial Fibrillation.